MedaRed (Seed)
Funding Details
- Awarder
- Inbox
- Date Award
- July 09, 2019
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $6,500,000
Company Info
- Founders
- Katerina Akassoglou
- Company Description
- MedaRed is a biotechnology company focused on discovering and developing new therapeutics targeting fibrin. The company is founded upon the pioneering work of Dr. Katerina Akassoglou, who discovered that fibrin is implicated in the toxic inflammation that damages neurons in neurological diseases including Alzheimer's disease and multiple sclerosis.
- Market
- Neurological diseases
- Location
- San Francisco, California, USA
- Coinvestors
- Dementia Discovery Fund, Dolby Family Ventures